Enrichment analysis of genes dysregulated following Sevoflurane treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013862
TitleEnrichment analysis of genes dysregulated following Sevoflurane treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Sevoflurane treated cells and untreated control cells.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088601
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorAxel
CREEDS IDdrug:2816
Drug NameSevoflurane
DrugBank IDDB01236
Organismhuman
PubChem CID5206
SMILES IDC(OC(C(F)(F)F)C(F)(F)F)F
Characteristic Direction parameters
Control SamplesGSM99229, GSM99252, GSM99255, GSM99258, GSM99268, GSM99280, GSM99289, GSM99293, GSM99298, GSM99305
Perturbed SamplesGSM99235, GSM99253, GSM99257, GSM99259, GSM99271, GSM99282, GSM99290, GSM99294, GSM99299, GSM99306
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE4386
Gene Expression Omnibus
Sevoflurane and propofol effect on the heart during off-pump coronary artery bypass graft surgery
14
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.